OncoDNA, The Cancer Theranostic Company is « L’Entreprise Prometteuse de l’Année » 2015
(‘Promising Company of the Year’ 2015)
On Monday 19th of October 2015, Ernst & Young, one of the world’s leading professional service organizations, was holding the twentieth edition of its contest “L’Entreprise de l’Année” (‘The Company of the Year’) which was attended by His Majesty King Philippe of Belgium. Pairi Daiza won the prize of ‘L’Entreprise de l’Année’ 2015.
A second prize was awarded that night with the title “L’Entreprise Prometteuse de l’Année” 2015 (‘Promising Company of the Year’ 2015). The winner of this third edition is OncoDNA, The Cancer Theranostic Company. The Walloon Minister of Economy, Jean-Claude Marcourt, handed over the prize to Jean-Pol Detiffe, OncoDNA CEO.
Ernst & Young Press Release – 19th October 2015
“The award of ‘L’Entreprise Prometteuse de l’Année’ was held for the third time for Brussels' and Walloon companies. The purpose of this award is to support a young company with high potential and in full development phase. As in previous years, four equal strength finalists competed to become 'L’Entreprise Prometteuse de l’Année' 2015: Domobios & Acar’Up, MyMicroInvest, OncoDna, The Cancer Theranostic Company and Universem. The company that was elected by the jury and which becomes the new winner 2015 is OncoDNA, The Cancer Theranostic Company. The winner succeeds CEFALY Technology, 'L’Entreprise Prometteuse de l’Année' 2014.
Pierre Rion, Chairman of the jury, states: "Out of the four promising candidates, the jury finally chose the company OncoDNA. The jury was particularly attracted by a very impressive growth at global level. The winner's business model is innovative and crystal clear: it is based on remarkable innovation in the area of the diagnosis, monitoring and treatment of cancer, highly advanced monitoring, and the power of a 'Big Data' network already under construction. The management team is well on its way to becoming a future winner of 'L’Entreprise de l’Année®'."